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Aims The non-invasive estimation of left ventricular filling pressures (LVFPs) represents a main goal in the clinical setting.
Current recommendations encourage the use of pulsed-wave Tissue Doppler for calculating the ratio between the
preload-dependent transmitral E velocity and the average of septal and lateral early diastolic velocities (e′) of the
mitral annulus. Despite its wide use, real utility of the E/e′ ratio has been recently challenged in patients with either
very advanced heart failure or preserved left ventricular (LV) ejection fraction. However, only few studies performed
the invasive and non-invasive estimation of LVFP simultaneously. The EURO-FILLING Study will validate the E/e′ ratio
(and additional non-invasive estimates) against simultaneously measured LVFP obtained by left heart catheterization in
a multicentre study involving reference European echo laboratories collecting a wide population sample size of
cardiac patients with and without heart failure.
Methods
and results
The EURO-FILLING study is a large, prospective observational study in which simultaneous assessment of invasive and
non-invasive measurements of LVFP will be acquired in eight reference European centres. Centralized reading of the col-
lected parameters will be performed in a core laboratory. Not only standardized echo Doppler measurements but also
novel echo parameters suchas LV global longitudinal strain and global atrial strain (obtainable by two-dimensional speckle
tracking echocardiography) will be tested for predicting invasive measurements of LVFP.
Conclusions The EURO-FILLING study is expected to provide important information on non-invasive assessment of LVFP and to
contribute to the standardization of this assessment in clinical practice.
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Rationale
Elevated left ventricular (LV) filling pressure (LVFP) is a major
determinant of cardiac symptoms and prognosis in patients with
chronic heart failure, regardless LVejection fraction (LVEF).1,2 The in-
vasive estimation of LVFP may be done either by right heart
catheterization which allows to measure pulmonary capillary
wedge pressure (PWCP) as an indirect, though accurate, estimate
of left atrial pressure3,4 or by direct sampling of LV cavity during
left heart catheterization.5
In this view, the non-invasiveestimation of LVFP is amain goal in the
management of cardiac patients. Non-invasive estimation of LVFP
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maybe obtained by Dopplerechocardiography.Current recommen-
dations6 encourage the use of pulse-wave Tissue Doppler for calcu-
lating the ratiobetween the preload-dependent transmitral E velocity
and the average of septal and lateral early diastolic velocities (e′) of
the mitral annulus. This parameter correlates with the rate of myo-
cardial relaxation and is relatively independent on pressure flow gra-
dients.6 In addition to be widely feasible and available, the E/e′ ratio
predicts the outcome in the settings of acute myocardial infarction,7
heart failure,8 arterial hypertension,9 and in patients mechanically
ventilated in intensive care unit.10 The E/e′ ratio is currently used in
clinical practice also to drive medical therapy and titrate cardiac
drugs in patients affected by chronic heart failure.11
Despite its wide use, the real utility of the E/e′ ratio has been
challenged in some studies, which included patients with either
very advanced heart failure12 or normal LVEF.13 In the latter con-
dition, the relationship between the E/e′ ratio and PWCP appeared
to be highly variable, especially after LVFP manipulation by pre-
load changes.13 A weak relationship between the E/e′ ratio and
left atrial pressure was also found in patients with hypertrophic
cardiomyopathy.14
Studies supporting11,15 –20 or contradicting12 –14 the concept
stating that the E/e′ ratio is a truly accurate estimate of LVFP have
common limitation. Indeed, all these studies been performed on rela-
tively small sample sizepopulationandwere mostlyperformed in one
centre. In addition, only fewstudiesperformed simultaneously the in-
vasive and non-invasive estimation of LVFP.11– 13,15–18 This was again
performedonrelatively small sample size series andprimarily using an
indirectmeasurement of LVFPsuchasPCWP(Table1). The simultan-
eity of these two assessments remains, however, an important pre-
requisite in order to avoid the main bias deriving from changes of
the haemodynamic conditions (e.g., heart rate, blood pressure,
blood volume) possibly occurring in the different moments in
which the two exams are performed.
The main aim of the EURO FILLING study is to validate Doppler
echocardiographic measurements of the E/e′ ratio—and additionally,
other currently used non-invasive estimates of LVFP—against the
simultaneous measurement of invasive LVFP, obtained by left heart
catheterization in a multicentre study involving reference European
echo labs. The study will collect a wide population sample size of
cardiac patients with and without heart failure.
The objectives of the EURO FILLING study will be the following:
(1) To assess the accuracy of E/e′ ratio (and additional, currently
used non-invasive estimates of LV filling pressure) in estimating
LVFP by using e′ average [(septal e′ + lateral e′)/2] in the
whole population and according to LVEF values (i.e. ≥50 and
,50%).
(2) To investigate the impact of sampling septal e′ and lateral e′ on
the accuracy of E/e′ ratio in estimating LVFP in the whole popu-
lation and according to LVEF values (≥50 and ,50%).
Study population
The EURO-FILLING will be a multicentre study involving eight refer-
encecentres acrossEurope, able to recruit consecutiveadult patients
of both genders undergoing clinically indicated coronary angiography
because of ascertained or suspected coronaryartery disease. Each la-
boratory will be requested to recruit patients with and without heart
failure (according to the 2012 ESC guidelines),21 and their history and
clinical status at the time of enrolment will be recorded. Each labora-
tory will be requested to include at least 10 consecutive patients with
normal LVEF ejection fraction (≥50%) and 10 consecutive patients
with reduced LVEF (,50%).
Exclusion criteria will include more than mild valvular heart
disease, valvular prosthesis, mitral annulus calcification, previous
myocardial infarction involving basal septum and/or basal lateral
wall, atrial fibrillation and severe arrhythmias precluding Doppler
analysis, left bundle branch block, any kind of pacemaker, hyper-
trophic cardiomyopathy, pericardial disease, and inadequate echo-
cardiographic imaging. Patients taking diuretics or vasodilators
(nitrates) on the day of the examination will also be excluded, since
such drugs could alter loading conditions (even if echo and invasive
measurements will be performed simultaneously as per protocol).
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Table 1 Main studies which assessed simultaneously E/e′ ratio and invasive left ventricular filling pressures








Nagueh SF et al., J Am Coll Cardiol, 1997 Patients with and without HF 60 Lateral PCWP r ¼ 0.87
Nagueh SF et al., Circulation, 1998 Patients with ST and HF 100 Lateral PCWP r ¼ 0.86
Nagueh SF et al., Circulation, 1999 HCM patients 35 Lateral Pre-A pressure r ¼ 0.76
Ommen SR et al., Circulation, 2000 HF patients 100 Lateral, septal, Avg M-LVDP r ¼ 0.51 lateral
r ¼ 0.64 septal
r ¼ 0.62 avg
Dokanish H et al., Circulation, 2004 ICU patients 50 Avg PCWP r ¼ 0.69
Mullens S et al., Circulation, 2009 HF patients with low EF (≤30%) 106 Lateral, septal, Avg PCWP r ¼ 0.14 lateral
r ¼ 0.18 septal
r ¼ 0.18 avg
Bhella PS et al., Circ Cardiovasc Imag, 2011 HF patients with normal EF (.50%) 47 Septal PCWP r2 ¼ 0.37
Nagueh SF Circ Cardiovasc Imag, 2011 Patients with decompensated HF 79 Average PCWP r ¼ 0.61
Avg, Average; EF, ejection fraction; HCM, hypertrophic cardiomyopathy; HF, heart failure; ICU, intensive care unit; PCWP, pulmonary capillary wedge pressure; M-LVDP, mean left
ventricular end-diastolic pressure; ST, sinus tachycardia.
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A preliminary comprehensive echo Doppler examination (including
the assessment of both LV and right ventricular chambers) will be
performed the same day but before (within 1/2h) the invasive and
non-invasive assessment of LVFP. Quantification of left ventricle
and left atrium geometry and function will be performed by 2-D
echocardiography according to ASE-EAE recommendations.22 Cal-
culation of LVEF will be done by modified Simpson’s rule. Tricuspid
annular plane systolic excursion will be used as an index of right ven-
tricular systolic function.
Each echocardiographic laboratory will provide simultaneous
non-invasive and invasive (left heart catheterization) estimation of
LVFP of all the recruited patients. This will be done in the catheteriza-
tion laboratory, in the samesupine bodyposition, immediately before
coronary angiography.
Measurements of invasive left ventricular
filling pressure
Invasive measurements will be taken by an end-hole catheter which
allows the most precise localization of the pressure measurement
and avoids any source of error due to catheter positioning.23 The
catheter will be connected with a pressure transducer and inserted
into LV chamber passing through the aortic valve in order to
measure early LV diastolic pressure, LV end-diastolic pressure
(LVEDP), and mean LV diastolic pressure (as the integral of the
area under the whole diastolic curve, from the time of mitral valve
opening to mitral valve closure) using a simultaneously recorded
ECG-derived R wave as a reference. The standardization of fre-
quency response will be at least 15–20 Hz, in order to obtain accur-
ate measurements, in particular of LVEDP. Values of invasive
pressures will be calculated as a mean of at least three consecutive
cardiac cycles.5 An accurate zero reference level is a prerequisite
for the reliable determination of intra-cardiac pressures. The mid-
chest position/level will be preferred as the zero reference point in
this study. A recordingof the zeroreferencewill beperformed imme-
diately before and after the LV pressure measurements. The zero
reference sampling will be saved together with the LV pressure
data. A core lab placed in Liege (Belgium), blinded to the echocardio-
graphic data, will read all pressure recordings.
Assessment of Doppler-derived left
ventricular diastolic function and left
ventricular filling pressure
The assessment of Doppler transmitral inflow diastolic filling and
pulsed wave Tissue Doppler of the mitral annulus will be performed
according to the standardized EAE procedures.6,24 Additional non-
invasive estimation of LVFP will include pulmonary venous flow para-
meters, pulmonary arterial systolic pressure, and global longitudinal
strain (GLS), while the quantification of global left atrial systolic
strain will be optional.
Performance recommendations
Transmitral pulsed Doppler will be recorded in the apical four-
chamber view. The pulsed Doppler sample volume of LV transmitral
inflow will be placed at the tips of mitral leaflets where the velocity
amplitude is maximal. When recording pulsed-wave Tissue
Doppler velocities of septal and lateral mitral annulus, special atten-
tion will be paid to the Doppler spectral gain settings and the velocity
scale will be kept at20 cm/s above and below the baseline. Minimal
angulation (,208) will be maintained between the ultrasound beam
and the direction of cardiac motion during the sampling of each of the
mitral annular sites.
Pulmonary venous flow will be recorded according to the ASE/
EAE standardized procedures by placing a pulsed Doppler sample
volume (2–3 mm) at 0.5 cm into the right upper pulmonary vein
for optimal recording of the spectral waveforms.6
Two-dimensional speckle tracking echocardiography (STE) of
the three apical views of the left ventricle will be acquired by
ASE/EAE standardized procedures, achieving appropriate frame
rates by the reduction of the number of ultrasound beams in
each frame (thereby reducing the spatial resolution and imaging
quality) and positioning the focus at an intermediate depth to op-
timize the images for STE. Sector depth and width will be adjusted
to include as little as possible outside the region of interest.24
Optional recording of apical four- and two-chamber views focused
on left atrium will be also acquired in order to estimate global left
atrial systolic strain.25
Reading recommendations
Measurements of parameters of LV diastolic function and non-
invasive LVFP will be done in the core laboratory by independent
experienced investigators who will be blinded to the results of
invasive haemodynamic data at the time of analysis. Early (E) and
atrial (A) peak velocities and their ratio, and E velocity deceleration
time will be measured. Using pulsed-wave Tissue Doppler, early
diastolic velocities (e′) will be measured at both septal and lateral
mitral annulus and averaged as recommended.4 The ratio of trans-
mitral peak E velocity to peak e′ velocity will be calculated as an
estimate of LVFP as the sole measurement of septal (E/e′S),
lateral annulus (E/e′L), and by averaging e′ of 2 sites (septal and
lateral: E/e′A2) (Figure 1).
Measurements of pulmonary venous flow will include peak systolic
velocity (S), peak anterograde diastolic velocity (D), the S/D ratio,
and the peak retrograde atrial reverse velocity (Ar) (Figure 2). The
time duration of Ar and the time difference between Ar and transmi-
tral A velocity (Ar 2 A) will also be calculated.
All reported echo-Doppler measurements will be averaged from
three cardiac cycles.
Using 2D STE, LV regional (18 segments) strain will be measured
and GLS will be obtained by averaging all values of LV regional peak
longitudinal strain obtained in each apical view before the aortic
valve closure (Figure 3) according to the ASE-EAE recommenda-
tions.25 Optional analysis of regional left atrial systolic strain will be
performed by using a 12-segment model (6 in apical 4 and 6 in
apical 2-chamber views) and QRS onset as the reference point
(Figure 4). Global atrial strain will be obtained by averaging all
values of regional peak atrial strain as recommended.25
Statistical analyses
All statistical analysis will be carried out by Julien Magne, the
appointed EACVI statistician. Data will be presented as mean
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value+ SD. The relationship between invasive and non-invasive
parameterswill be assessedusing linear regression.Multiple linear re-
gression analysis will be performed to identify the independent con-
tributors of invasive LVFP in the whole population, as well as
according to the LVEF values (≥50 and ,50%). Concordance of in-
vasive measurements and non-invasive estimates of LVFP will be
assessed using the Bland–Altman analysis. Receiving operating
characteristic curves will be constructed and the area under the
curves determined for the prediction of LVEDP ≥15 (pathologic
cut-off point) and≥18 mm Hg (prognostic cut-off point). Sensitivity,
specificity, positive predictive value, and negative predictive value
predicting LVEDP ≥15 and ≥18 mm Hg will be calculated for
various cut-off values of each non-invasive parameters (including
the predefined ratio). In addition, the independent predictor of
LVEDP ≥15 and ≥18 mm Hg will be identified using logistic
regression. The null hypothesis will be rejected at P ≤ 0.05.
Quality control of the study
Each peripheral echocardiographic laboratory will follow the stand-
ard operational procedures recommended by principal investigators
(PI) and core laboratory in terms of data imaging acquisition, data
storage, and data processing.
The core laboratory will be organized to ensure the quality control
of echo Doppler exams performed in peripheral echocardiographic
laboratories and optimize reading procedures in order to limit the
inter- and intra-observer variability of measurements. Internal repro-
ducibility of core laboratory will be checked (the Bland & Altman test;
interclass correlation coefficient, inter-rater agreement: kappa) on a
limited data set of invasive and non-invasive LVFP. Continuous links
will be kept between core laboratory and PI during the overall
study duration period.
Figure 2: Methodology of measurement of pulmonary venous
flow velocity. Pulmonary venous flow pattern obtained by pulsed
Doppler sample volume at 0.5 cm into the right upper pulmonary
vein. AR, atrial reverse velocity; D, early diastolic velocity; S, systolic
peak velocity.
Figure 1: Methodology to calculate the ratio between standard Doppler derived transmitral early diastolic velocity (E) and pulsed Doppler
derived early diastolic velocity of the mitral annulus (e′). The e′ velocity can be measured either at the septal site or at the lateral site of the
mitral annulus. However, recommendations on LV diastolic function encourage the average of septal and lateral e′ velocities.
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The EURO-FILLING study will be conducted according to the rules
for research in human subjects. Protection of privacy with regards to
processing of individual data will be ensured. The institutional ethical
committees of the participating centres will approve the project. All
patients will give their written informed consent.
Discussion
Non-invasive estimation of LVFP is critically important in the clinical
setting in relation to its diagnostic and prognostic implications and
also in order to manage heart failure patients with appropriate
cardiac therapy and timing.1– 11 Despite being largely applied in the
current practice and encouraged by echocardiographic recommen-
dations,6 the use of E/e′ ratio remains controversial in heart failure
patients with either normal or depressed LVEF.11 –18 A main weak
point of this debate depends on the fact that only few studies per-
formed a simultaneous assessment of the E/e′ ratio (or other non-
invasive estimate) and invasively measured LVFP, on a relatively
small sample size population.11–13,15– 20
The EURO-FILLING study aims to establish associations between
simultaneously determined invasive and non-invasive measurements
of LVFP in a large population of consecutive patients undergoing
cardiac catheterization because of suspected or ascertained coron-
ary artery disease. The EURO-FILLING study will be the largest pro-
spective study to explore this issue in patients with both normal and
reduced LVEF by a multicentre approach which will involve reference
EACVI echocardiographic laboratories across Europe. Not only
the E/e′ ratio but also the other currently used diastolic parameters
(e.g. mitral inflow derived E velocity deceleration time, Ar-A time
duration difference, pulmonary arterial systolic pressure) will be
Figure 3: Speckle tracking echocardiography (STE)-derived left ventricular (LV) longitudinal strain during cardiac cycle in the three apical views.
In the left section of each view colour representation of STE on 2-D imaging (upper) and quantitation of peak regional strain values (normally nega-
tive) referring to six myocardial regions. In the right upper section of eachviewregional colour systolic curvesof systolic strain while dotted white line
corresponds to average strain (GLS). In the right lower section qualitative colour M-mode strain representation referring to the six consecutive
myocardial segments: at the bottom LV basal right segments (red colour) of each view, at the central part LV apex, at the top LV basal left segments
(yellow colour) of each view; red and pink colours refer to systolic deformation.
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tested against measurements obtained simultaneously by left heart
catheterization. Also measurements derived by new advanced echo-
cardiographic technologies (e.g. LV GLS and global left atrial systolic
strain) will be investigated in order to provide a comprehensive as-
sessment of non-invasive LVFP. Of interest, preliminary results
have demonstrated the ability of left atrial systolic strain in predicting
invasive LVFP.26 In this regards, no information is available for GLS
while preliminary data have been obtained with global diastolic
strain rate.27,28
Notably, the quality assurance of the EURO FILLING study will be
guaranteed by adequately trained operators of reference peripheral
sites but also by using a dedicated core laboratory with personnel
having considerable technical skills and experience in research
projects. The core laboratory will verify the exams obtained in the
peripheral centres in terms of completeness, adherence to the
acquisition protocol, and data quality. It will also provide valuable
determination of invasive and non-invasive measurements according
to the standardized procedures.23
Limitations
The use of an end-hole catheter for measuring invasive LVFP can
be considered a limitation of this project. Micromanometer-
tipped catheters provide globally more accurate pressures also in
inexperienced haemodynamic laboratories. Unfortunately, they are
expensive and also associated with higher risk of embolus. Converse-
ly, end-hole catheters can be standardized (zeroing) from the level of
the heart in each patient as an absolute pressure reference.
Conclusions
The EURO-FILLING study will test the accuracy of the E/e′ ratio and
other echocardiographic Doppler measurements in predicting inva-
sively determined LVFP. The strength of the study will be the simul-
taneous assessment of invasive and non-invasive measurements,
the involvement of reference centres across Europe, and the use of
a dedicated core laboratory which will validate the obtained mea-
surements.
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lecture honoraria from General Electric Healthcare.
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